Edition:
United States

Bure Equity AB (BURE.ST)

BURE.ST on Stockholm Stock Exchange

98.80SEK
23 May 2018
Change (% chg)

0.40kr (+0.41%)
Prev Close
98.40kr
Open
98.40kr
Day's High
98.80kr
Day's Low
97.50kr
Volume
164,459
Avg. Vol
86,746
52-wk High
115.00kr
52-wk Low
86.80kr

Summary

Name Age Since Current Position

Patrik Tigerschiold

54 2013 Chairman of the Board

Henrik Blomquist

46 2014 President, Chief Executive Officer

Max Jonson

49 2013 Chief Financial Officer

Fredrik Mattsson

46 Investment Director

Philip Nyblaeus

35 2015 Investment Manager

Elisabet Hellman

60 2016 Executive Assistant

Oskar Hornell

30 2015 Analyst

Gosta Johannesson

59 Senior Advisor

Samir Kamal

53 Senior Advisor

Trolle Sahlstrom

29 2017 Analyst

Carl Bjorkman

47 2010 Director

Bengt Engstrom

65 2014 Independent Director

Charlotta Falvin

52 2015 Independent Director

Sarah McPhee

63 2016 Independent Director

Mathias Uhlen

64 2010 Independent Director

Biographies

Name Description

Patrik Tigerschiold

Mr. Patrik Tigerschiold has served as Chairman of the Board of Directors of Bure Equity AB since April 22, 2013. Before that, he had been Chief Executive Officer (CEO) of the Company from February 2010 until April 22, 2013. He was also Chairman from 2004 until 2009. He has been employed by the Company since 1999 (employed at Skanditek until 2010). He is Member of the Investment and Nominating Committees. In addition, he acts as Chairman of the Boards of Directors at Mycronic AB, the Association for Generally Accepted Principles in the Securities Market, the Swedish Association of Listed Companies and Bure Financial Services AB, as well as Member of the Board of Directors at Stockholms Universitet, Cavotec SA, Fondbolaget Fondita Ab and Idevall & Partners Fonder AB. He holds a Master of Science degree in Business and Economics.

Henrik Blomquist

Mr. Henrik Blomquist has served as President and Chief Executive Officer of Bure Equity AB since February 20, 2014. Before that, he has been Acting Chief Executive Officer of the Company since April 22, 2013. Before that, he has been Deputy Chief Executive Officer of the Company since October 2010. He is Member of the Investment Committee. He has been employed at the Company since 1999 (employed at Skanditek until 2010). In addition, he acts as Chairman of the Boards of Directors at Mercuri International Group AB, Investment AB Bure, Bure Growth AB and Cavena Image Products AB, as well as Member of the Boards of Directors at of Lauritz.com Group A/S, MedCap AB, Bure Financial Services AB, among others. He has experience of investment operations and corporate development. He completed Economic studies.

Max Jonson

Mr. Max Jonson has been appointed Chief Financial Officer at Bure Equity AB, effective as of October 1, 2013. He previously served as Chief Financial Officer at IFL at Handelshogskolan in Stockholm, and Chief Financial Officer at Orasolv and DPNova. He also worked with corporate finance at SEB Enskilda and Kaupthing Bank, among others. He is Board Member of Bure Financial Services AB, Bure Growth AB, BioLamina AB and Celemi International AB.

Fredrik Mattsson

Mr. Fredrik Mattsson serves as Investment Director at Bure Equity AB. He has been employed by the Company since 2009 (employed at Skanditek until 2010). He also acts as Chairman of the Board of Directors of Xvivo Perfusion AB, BioLamina AB and Celemi International AB, as well as Member of the Boards of Directors at Vitrolife AB, Bure Growth AB, among others.

Philip Nyblaeus

Mr. Philip Nyblaeus has served as Investment Manager at Bure Equity AB since 2015. He was Analyst at the Company until 2015. He has been employed by the Company since 2011. He is also Board Member of Vigmed Holding AB and Investment AB Bure.

Elisabet Hellman

Oskar Hornell

Gosta Johannesson

Mr. Gosta Johannesson serves as Senior Advisor at Bure Equity AB. He has been Consultant since April 2013. He is Board Member of Xvivo Perfusion AB, Axiell Group AB, Interflora AB, among others. He also serves as Chairman of Idevall & Partners Fonder AB.

Samir Kamal

Mr. Samir Kamal serves Senior Advisor at Bure Equity AB. He has been Consultant since September 2013. He is also Board member of Bonava AB, Scandi Standard AB and Save by Solar AB.

Trolle Sahlstrom

Carl Bjorkman

Mr. Carl Bjorkman has served as Member of the Board of Directors at Bure Equity AB since April 2010. He acts as Chairman of the Boards of Directors at Cality Invest AB and Board Member of Ballsta Mekaniska AB, Staketsholms Forvaltnings AB, Johan Bjorkman’s Public Benefit Foundation for Economic Research and FPG Media AB. He holds Master of Science degree in Engineering.

Bengt Engstrom

Mr. Bengt G. Engstrom has been Independent Member of the Board of Directors of Bure Equity AB since April 24, 2014. He is Chairman of the Board of Scandinavian Executive AB, Chamber AB and Real Holding AB, as well as Board Member of ScandiNova AB, Scanfil Oy, Prevas AB, Advania AB, Avaj International Holding AB. He holds Master of Science degree in Engineering.

Charlotta Falvin

Ms. Charlotta Falvin has been Independent Director at Bure Equity AB since May 4, 2015. She holds Master of Science in Business and Economics. She is Chairman of Ideon Open AB, School of Engineering at Lund University and SHB sodra regionbank, as well as Board member of CLX Communications AB, Doro AB, Invisio Communications AB, NetInsight AB, the Chamber of Commerce and Industry of Southern Sweden and member of the Advisory Board of the Sten K. Johnson Centre for Entrepreneurship at Lund University.

Sarah McPhee

Ms. Sarah McPhee has been Independent Member of the Board of Directors of Bure Equity AB since May 9, 2016. She holds Master of Science degree in Economics and Master of Arts and Bachelor of Arts degrees. She is also Chairman of SNS and Fjarde AP-fonden, and Board Member of Axel Johnson Inc and Klarna AB.

Mathias Uhlen

Mr. Mathias Uhlen has served as Independent Member of the Board of Directors at Bure Equity AB since February 2010. He is also Chairman of the Boards of Directors at Atlas Antibodies AB and Antibodypedia AB, as well as Member of the Boards of Directors at Affibody Holding AB, SweTree Technologies AB, Alligator AB, Stockholm Science City Foundation and Novozymes A/S. In addition, he is Member the Royal Swedish Academy of Sciences (KVA) and the Royal Swedish Academy of Engineering Sciences (IVA) as well as National Academy of Engineering (NAE) in the United States. He holds a Doctorate of Philosophy degree in Engineering and he is Professor of Microbiology at Kungliga Tekniska Hogskolan - KTH.